Clinical Trials Logo

Clinical Trial Summary

In spite of advances in neonatal intensive care allowing the first generation survivors of extreme prematurity to now reach young adulthood, these individuals present with reduced exercise capacity; a strong predictor of later chronic disease and mortality. The reason why individuals born preterm have exercise limitation remains unclear and may be a consequence of impact of preterm birth and associated neonatal difficulties on the development of organs important for exercise, namely the lungs, the heart, the vessels (which bring blood and oxygen to the muscles) and the muscles. It is well known that exercise benefits overall health in at-risk as well diseased populations. However, whether exercise training can improve fitness in young adults born preterm was not demonstrated and whether the cardiovascular, pulmonary and muscle impairments associated with preterm birth are reversible through exercise intervention in young adulthood is unknown.


Clinical Trial Description

The investigators postulate that a 14-week exercise intervention will improve exercise capacity in preterm adults, as seen in other at-risk populations, in correlation with measures of vascular health, heart and muscle perfusion and oxygenation, and pulmonary function detected by cutting edge and highly sensitive imaging and circulating biomarkers. These markers are more sensitive to pre-disease changes than traditional health measures, and are largely unexplored in preterm populations. The investigators will: 1. Determine whether a 14-week supervised exercise training improves exercise capacity in young adults (18-29 years old) born very preterm at <29 weeks gestational age. 2. Examine whether improvement in exercise capacity is associated with changes in (a) markers of vascular health including circulating endothelial progenitor cells and microparticles, (b) cardiac perfusion by cutting-edge oxygenation-sensitive cardiovascular magnetic resonance imaging (MRI), (c) lung regional ventilation measured by newly developed hydrogen proton (1H) MRI, (d) muscle oxygenation during exercise. 3. Compare the response of the above measures to exercise intervention between young adults born very preterm and term controls. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03504215
Study type Interventional
Source St. Justine's Hospital
Contact
Status Completed
Phase N/A
Start date March 2, 2018
Completion date January 27, 2021

See also
  Status Clinical Trial Phase
Completed NCT03641209 - Extremely Low Gestatonal Age Infants' Paracetamol Study Phase 1/Phase 2
Recruiting NCT04114435 - Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
Completed NCT04639583 - Use of NIRS in Preterm Population Born at Altitude N/A
Recruiting NCT04294368 - Targeted Fortification of Donor Breast Milk in Preterm Infants N/A
Recruiting NCT05615311 - Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm Phase 1/Phase 2
Recruiting NCT04735315 - Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study
Completed NCT05684419 - Preterm Infants Born to Homeless Mothers.
Recruiting NCT04270240 - A NEW SCORING SYSTEM FOR PREDICTION OF PDA
Completed NCT04535375 - Sonographic QUantification of Venous Circulation In the Preterm Brain N/A
Recruiting NCT05280340 - Anakinra for Preterm Infants Pilot Phase 1/Phase 2
Recruiting NCT05827250 - Vibroacoustic Study of Lung Development in Newborn Infants
Recruiting NCT05824377 - To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation. N/A
Completed NCT03635944 - Nutritional Care and Head Growth in Preterm Infants
Completed NCT03261609 - Risk of Chronic Diseases in Young Adults Born Preterm: Relationship With Inflammation and Oxidative Stress Biomarkers.
Active, not recruiting NCT04325308 - Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk N/A
Active, not recruiting NCT04545866 - The Budesonide in Babies (BiB) Trial Phase 3